Gilead Sciences officer proposes $4.78M share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Gilead Sciences, Inc. officer Johanna Mercier gave notice of a proposed sale of 28,000 common shares, with an approximate sale date of November 16, 2026 and aggregate market value of $4,775,527.25. The securities information lists 3,000 performance shares acquired February 4, 2025 and 25,000 shares from a cash stock-option exercise dated November 16, 2026.
The notice lists February 20, 2025 as the plan adoption or instruction date if relying on Rule 10b5-1. It also reports three common-stock sales during the preceding three months.
Key Figures
Key Terms
Rule 10b5-1 regulatory
Stock Option Exercise financial
Aggregate Market Value financial
Gross Proceeds financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What were Johanna Mercier's previous GILD stock sales?
What Rule 10b5-1 date does Johanna Mercier's GILD notice list?
AI-generated analysis. How Rhea-AI works. Not financial advice.